IRTC(iRhythm Holdings, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $322.82M | $410.92M | $492.68M | $591.84M | $747.14M |
| 毛利润 | $213.57M | $281.63M | $331.81M | $407.53M | $527.25M |
| 营业利润 | −$99.94M | −$113.78M | −$125.16M | −$115.50M | −$57.41M |
| 净利润 | −$101.36M | −$116.16M | −$123.41M | −$113.29M | −$44.55M |
| 经营现金流 | −$37.75M | −$23.01M | −$50.10M | $3.39M | $80.86M |
| 自由现金流 | −$65.82M | −$52.84M | −$90.53M | −$30.55M | $34.52M |
| 摊薄每股收益 | $-3.46 | $-3.88 | $-4.04 | $-3.63 | $-1.39 |